IP Library Granted Patent US 9,861,656
Granted Patent B2
US 9,861,656 · App. 15/256,245 · Granted Jan 9, 2018

Phospholipid compositions and use thereof to enhance spermatozoa motility and viability

Inventors: Garth Nicolson (Huntington Beach, CA); Gonzalo Ferreira de Mattos (Montevideo, UY); Robert A. Settineri (Irvine, CA)
Assignee: ALLERGY RESEARCH GROUP, LLC
A61K31/733A61K31/661A61K31/683A61K31/685A61K31/70C12N5/061C12N2500/05C12N2500/32C12N2500/34C12N2500/38C12N2501/90C12N2501/999
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,656
App. No.
15/256,245
Granted
Jan 9, 2018
Kind
B2
Abstract

Sperm mobility and impregnation of an oocyte is enhanced by placing sperm in an aqueous solution of phospholipids prior to in vitro fertilization or artificial insemination. The aqueous phospholipid solution can also be used during storage or cryopreservation of the sperm. Also, the motility of sperm produced or ejaculated and the environment into which it is placed is enhanced my ingestion of the phospholipid composition by the male or female, or a vaginal placement of compositions containing the phospholipids.

Claims (27)

1. A method of increasing sperm motility comprising delivering to a sexual organ of a male mammal, a female mammal or both a male and female mammal a composition comprising an effective amount of inulin and a mixture of phospholipids, said inulin and phospholipids delivered in the form of a vaginal cream, jelly, foam, gel, lubricant, or a suppository.

2. The method of claim 1 wherein the mixture of phospholipids comprises phosphatidylglycerol and one or more phospholipids selected from the group consisting of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), and one or more of linoleic acid (LA) and phosphatidic acid.

3. A method of increasing sperm motility comprising delivering to a male mammal, a female mammal or both a male and female mammal a composition comprising an effective amount of inulin and a mixture of phospholipids, wherein the composition is delivered in the form of

a) a tablet, capsule or powder, said powder added to a food product, blended into a beverage or compressed into a chewable tablet or

b) provided as 0.1 to 4% of a vaginal cream, jelly, foam, gel, lubricant or a suppository, wherein the phospholipid mixture comprises 19-29% phosphatidylcholine (PC), 15-25% phosphatidylethanolamine (PE), 3.5-10% phosphatidic acid (PA), 10-18% phosphatidylinositol (PI), 2-10% phosphatidylglycerol (PG), 10-20% glycolipids and 5-11% other phospholipids.

4. A method of increasing the likelihood of fertilization of a female oocyte by a sperm cell comprising delivering to a sexual organ of a male mammal, a female mammal or both a male and female mammal a composition comprising an effective amount of inulin and a mixture of phospholipids, said inulin and phospholipids delivered in the form of a vaginal cream, jelly, foam, gel, lubricant, or a suppository.

5. The method of claim 4 wherein the mixture of phospholipids comprises phosphatidylglycerol and one or more phospholipids selected from the group consisting of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), and one or more of linoleic acid (LA) and phosphatidic acid.

6. A method of increasing the likelihood of fertilization of a female oocyte by a sperm cell comprising delivering to a male mammal, a female mammal or both a male and female mammal a composition comprising an effective amount of inulin and a mixture of phospholipids, wherein the composition is delivered in the form of

a) a tablet, capsule or powder, said powder added to a food product, blended into a beverage or compressed into a chewable tablet or

b) provided as 0.1 to 4% of a vaginal cream, jelly, foam, gel, lubricant or a suppository, wherein the phospholipid mixture comprises 19-29% phosphatidylcholine (PC), 15-25% phosphatidylethanolamine (PE), 3.5-10% phosphatidic acid (PA), 10-18% phosphatidylinositol (PI), 2-10% phosphatidylglycerol (PG), 10-20% glycolipids and 5-11% other phospholipids.

7. A method of increasing the motility of sperm comprising depositing the sperm in an aqueous solution, the aqueous solution having an effective amount of inulin and a mixture of phospholipids dissolved therein.

8. The method of claim 7 wherein the mixture of phospholipids comprises phosphatidylglycerol and one or more phospholipids selected from the group consisting of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), and one or more of linoleic acid (LA) and phosphatidic acid.

9. The method of claim 7 wherein the inulin and the mixture of phospholipids dissolved in the aqueous solution comprises 0.1 to 4% of the aqueous solution.

10. The method of claim 7 wherein the phospholipid mixture comprises: 19-29% phosphatidylcholine (PC), 15-25% phosphatidylethanolamine (PE), 3.5%-10% phosphatidic acid (PA), 10-18% phosphatidylinositol (PI), 2-10% phosphatidylglycerol (PG), 10-20% glycolipids and 5-11% other phospholipids.

11. A method of increasing the likelihood of fertilization of a female ovum in vitro by a sperm cell comprising placing the sperm cells and ovum in an aqueous composition comprising an effective amount of inulin and a mixture of phospholipids.

12. The method of claim 11 where in the mixture of phospholipids comprises phosphatidylglycerol and one or more phospholipids selected from the group consisting of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), and one or more of linoleic acid (LA) and phosphatidic acid.

13. The method of claim 11 wherein said inulin and phospholipids in the aqueous solution comprise 0.1 to 4% of the aqueous solution.

14. The method of claim 11 wherein the phospholipid mixture comprises:

19-29% phosphatidylcholine (PC),

15-25% phosphatidylethanolamine (PE),

3.5%-10% phosphatidic acid (PA),

10-18% phosphatidylinositol (PI),

2-10% phosphatidylglycerol (PG),

10-20% glycolipids and

5-11% other phospholipids.

15. The method of claim 1 where in combination of inulin and phospholipids comprises 0.1 to 4% of the vaginal cream, jelly, foam, gel, lubricant or a suppository.

16. The method of claim 4 where in combination of inulin and phospholipids comprises 0.1 to 4% of the vaginal cream, jelly, foam, gel, lubricant or a suppository.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: ALLERGY RESEARCH GROUP, LLC.
To: NUTRITIONAL THERAPEUTICS, INC.
Reel/Frame 054027/0055 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2016
From: NICOLSON, GARTH; FERREIRA DE MATTOS, GONZALO; SETTINERI, ROBERT A.
To: ALLERGY RESEARCH GROUP, LLC
Reel/Frame 039625/0993 →
Continuity (6)
Continuation In Part 14815841 · Jul 31, 2015
Continuation In Part 14152938 · Jan 10, 2014
Continuation In Part 13208255 · Aug 11, 2011
Provisional Application 62245868 · Oct 23, 2015
Provisional Application 62216269 · Sep 9, 2015
Related Publication 20160367590A1 · Dec 22, 2016